Depression & HIV: assessment and treatment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Depression & HIV: assessment and treatment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

STEP Perspect. 1997 Winter;9(1):1-5. Unique Identifier : AIDSLINE AIDS/97702555
Elliott A; University of Washington, Madison Clinic, Seattle, WA.


Abstract: Although the advent of protease inhibitors has greatly extended the life expectancy of those living with HIV, they also have introduced the problems of emotionally dealing with a chronic illness. Depression appears to be the most common psychiatric disorder found among HIV-infected individuals. Preliminary evidence suggests that depressive symptoms may be associated with increased mortality. Treatment options are discussed, including psychotherapy and treatment with pharmaceuticals.
Keywords: Antidepressive Agents/*THERAPEUTIC USE Combined Modality Therapy Cytochrome P-450/METABOLISM Depressive Disorder/COMPLICATIONS/*PSYCHOLOGY/THERAPY Drug Interactions HIV Infections/COMPLICATIONS/DRUG THERAPY/*PSYCHOLOGY HIV Protease Inhibitors/METABOLISM Human *Psychotherapy Risk Factors Ritonavir/METABOLISM NEWSLETTER ARTICLEKWDantidepressiveagents/KWDtherapeuticusecombinedmodalitytherapycytochromep-450/metabolismdepressivedisorder/complications/KWDpsychology/therapydruginteractionshivinfections/complications/drugtherapy/KWDpsychologyhivproteaseinhibitors/metabolismhumanKWDpsychotherapyriskfactorsritonavir/metabolismnewsletterarticle
970830
M9781196

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .